Isabelle Ducellier - BioGaia AB CEO Pres
| BIOG-B Stock | SEK 105.80 1.10 1.05% |
Insider
Isabelle Ducellier is CEO Pres of BioGaia AB
| Age | 54 |
| Phone | 46 8 55 52 93 00 |
| Web | https://www.biogaia.com |
BioGaia AB Management Efficiency
The company has return on total asset (ROA) of 0.1041 % which means that it generated a profit of $0.1041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1941 %, meaning that it generated $0.1941 on every $100 dollars invested by stockholders. BioGaia AB's management efficiency ratios could be used to measure how well BioGaia AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Helena Bramstorp | Novotek AB | 41 | |
| Ulrika Palm | Midsona AB | 50 | |
| Priscilla Kazumba | C Rad AB | N/A | |
| Tobias Traneborn | Midsona AB | 48 | |
| Lars Levin | C Rad AB | 52 | |
| Niklas Carln | Stille AB | 49 | |
| Hakan Axelsson | C Rad AB | 55 | |
| Peter sberg | Midsona AB | 57 | |
| Veronika Grozdanovska | Novotek AB | 53 | |
| Erk Schuchhardt | Midsona AB | N/A | |
| Xiaodong Wang | C Rad AB | 44 | |
| Emelie Gozzi | C Rad AB | N/A | |
| Antti MP | Novotek AB | 45 | |
| Tim Thurn | C Rad AB | 42 | |
| Marjolaine CevozGoyat | Midsona AB | N/A | |
| Max Bokander | Midsona AB | 50 | |
| Tobias Antius | Novotek AB | 51 | |
| Ivan Astralaga | C Rad AB | N/A | |
| Hanna Wilkman | Stille AB | 56 | |
| John Anderson | Stille AB | 48 | |
| Tora Molander | Midsona AB | 45 | |
Management Performance
BioGaia AB Leadership Team
Elected by the shareholders, the BioGaia AB's board of directors comprises two types of representatives: BioGaia AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioGaia. The board's role is to monitor BioGaia AB's management team and ensure that shareholders' interests are well served. BioGaia AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioGaia AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gianfranco Grompone, Chief RD | ||
| Eva Nelson, Co Mang | ||
| Sebastian Heimfors, VP Officer | ||
| MBA Econ, Founder Chairman | ||
| Isabelle Ducellier, CEO Pres | ||
| Marika Isberg, Regulatory Legal | ||
| Angelika Kjelldorff, VP HR | ||
| Linda Hagglund, VP Marketing | ||
| Alexander M, Ex CFO | ||
| Jens Velling, Chief Officer |
BioGaia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioGaia AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.34 % | |||
| Operating Margin | 0.33 % | |||
| Current Valuation | 7.35 B | |||
| Shares Outstanding | 97.28 M | |||
| Shares Owned By Insiders | 3.59 % | |||
| Shares Owned By Institutions | 50.15 % | |||
| Price To Earning | 33.68 X | |||
| Price To Book | 4.77 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BioGaia Stock
BioGaia AB financial ratios help investors to determine whether BioGaia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioGaia with respect to the benefits of owning BioGaia AB security.